Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum.

about

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis.Dose escalation studies with caspofungin against Candida glabrata.

P2860

Q35689690-678983BE-B588-431A-85C3-5EE16246742C Q36376559-EACB7368-BFDE-4381-B685-7E39E95C6E73

P2860

Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum.

Item

http://www.wikidata.org/entity/Q44583206

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Killing rates for caspofungin ...... presence and absence of serum.

@en

Killing rates for caspofungin ...... presence and absence of serum.

@nl

type

Item

label

Killing rates for caspofungin ...... presence and absence of serum.

@en

Killing rates for caspofungin ...... presence and absence of serum.

@nl

prefLabel

Killing rates for caspofungin ...... presence and absence of serum.

@en

Killing rates for caspofungin ...... presence and absence of serum.

@nl

P1476

Killing rates for caspofungin ...... presence and absence of serum.

@en

P2093

David S Perlin

http://www.w3.org/2001/XMLSchema#string

Gábor Kardos

http://www.w3.org/2001/XMLSchema#string

László Majoros

http://www.w3.org/2001/XMLSchema#string

Marianna Domán

http://www.w3.org/2001/XMLSchema#string

Réka Berényi

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.

Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity.

Phase II dose escalation study of caspofungin for invasive Aspergillosis.

Anidulafungin is fungicidal and exerts a variety of postantifungal effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates.

Evaluation of the new Micronaut-Candida system compared to the API ID32C method for yeast identification.

Characterising the post-antifungal effects of micafungin against Candida albicans, Candida glabrata, Candida parapsilosis and Candida krusei isolates.

Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments.

Elevated chitin content reduces the susceptibility of Candida species to caspofungin.

Paradoxical effect of caspofungin against Candida bloodstream isolates is mediated by multiple pathways but eliminated in human serum.

P2888

s11046-014-9799-4

P304

197-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11046-014-9799-4

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

Rudolf Gesztelyi

Renátó Kovács

P577

2014-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264798695

http://www.w3.org/2001/XMLSchema#string

P698

25118874

http://www.w3.org/2001/XMLSchema#string

Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum.

about

P2860

P2860

Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698